SK
Suresh Kumar Mishra
About Suresh Kumar Mishra
Data last updated:
Suresh Kumar Mishra is a Director at Bendic Health Care Private Limited (since 2017) and Director at Xyden Health Care Private Limited (since 2021). The companies operate in Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹5.25 Cr; the largest is Bendic Health Care Private Limited at ₹3.86 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Dec 2017 | 2017 | ₹3.86 Cr (FY 2025) | Active | |
| Director | 29 Apr 2021 | 2021 | ₹1.39 Cr (FY 2025) | Active |
Board colleagues of Suresh Kumar Mishra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vinod Kumar Chaturvedi | 07965233 | Bendic Health Care Private Limited , Xyden Health Care Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suresh Kumar Mishra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suresh Kumar Mishra
Suresh Kumar Mishra currently holds 2 directorships: Bendic Health Care Private Limited (Director, since 01 Dec 2017, revenue ₹3.86 Cr (FY 2025)); Xyden Health Care Private Limited (Director, since 29 Apr 2021, revenue ₹1.39 Cr (FY 2025)).
Suresh Kumar Mishra was first appointed on 01 Dec 2017 as Director at Bendic Health Care Private Limited. The most recent appointment on record is 29 Apr 2021 at Xyden Health Care Private Limited.
The 2 current companies of Suresh Kumar Mishra that report revenue have a combined latest revenue of ₹5.25 Cr: Bendic Health Care Private Limited ₹3.86 Cr (FY 2025); Xyden Health Care Private Limited ₹1.39 Cr (FY 2025).
The current boards of Suresh Kumar Mishra's companies include Vinod Kumar Chaturvedi (Bendic Health Care Private Limited).